Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $792.00M.
ENTERPRISE VALUE (EV)
$792.00M
Lexicon Pharmaceuticals, Inc.
Market Cap
$770.68M
Enterprise Value (EV)
$792.00M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lexicon Pharmaceuticals, Inc. (LXRX) | $770.68M | $792.00M |
| Geron Corporation (GERN)vs › | $769.83M | $829.33M |
| Mesa Laboratories, Inc. (MLAB)vs › | $766.58M | $837.24M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $755.39M | $726.89M |
| Design Therapeutics, Inc. (DSGN)vs › | $748.55M | $737.67M |
| Gyre Therapeutics, Inc. (GYRE)vs › | $790.46M | $750.59M |
| AdaptHealth Corp. (AHCO)vs › | $792.17M | $2.81B |
| Cytek Biosciences, Inc. (CTKB)vs › | $744.51M | $697.12M |
| Candel Therapeutics, Inc. (CADL)vs › | $743.69M | $591.64M |
| InMode Ltd. (INMD)vs › | $805.89M | $414.16M |
Market Cap
$770.68M
Total Debt
$55.65M
Cash
$34.33M
Enterprise Value
$792.00M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
